Aaron Iding and Colleagues on Additional Oxerutin Link to DVT
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Oxerutin therapy alongside standard treatment reduced residual venous obstruction in deep vein thrombosis patients, potentially lowering postthrombotic syndrome risk compared to standard treatment alone.
Authors: Aaron Iding, Ruben Hupperetz, Rutger Brans, Hugo Ten cate, Daan van Twist, Arina J. Ten Cate-Hoek”
Read the full article here.
Article: Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Authors: Aaron Iding, Ruben D. Hupperetz, Rutger J. B. Brans, Hugo ten Cate, Daan J. L. van Twist, Arina J. ten Cate-Hoek
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 28, 2026, 15:10Ify Osunkwo: Strengthening Sickle Cell Care Systems at Global Conference in Nairobi
-
Aug 28, 2026, 15:08Muhammed Safvan: One Drop of Blood Can Tell a Story
-
Aug 28, 2026, 14:52Jessica Lee: Standing Together for Children and Families with Bleeding Disorders
-
Aug 28, 2026, 14:45Daisy Souster: A New Chapter in Bleeding Disorder Advocacy
-
Aug 28, 2026, 14:42Oluwatoyin Iyabode Ajayi: Heavy Periods – When Is Menstrual Bleeding Too Much?
-
Aug 28, 2026, 14:20Alyson Reidy: Factor Man and Community Support Take Center Stage at NBDF 2026
-
Aug 28, 2026, 14:09New Study Highlights Pregnancy Challenges in Inherited Bleeding Disorders – Glanzmann’s Research Foundation
-
Aug 28, 2026, 13:55Swatee C: A Guide to Common Uterine Disorders
-
Aug 28, 2026, 12:14Gathoni Kungu: Run to End Postpartum Hemorrhage and Save Lives